Data di Pubblicazione:
2006
Citazione:
A review of guidelines for antibacterial use in acute exacerbations of chronic bronchitis / F. Blasi, S.Ewig, A.Torres, G Huchon. - In: PULMONARY PHARMACOLOGY & THERAPEUTICS. - ISSN 1094-5539. - 19:5(2006), pp. 361-369.
Abstract:
Acute exacerbations of chronic bronchitis (AECB) affect a significant proportion of the adult population worldwide and are associated
with a substantial socioeconomic burden. The majority of episodes of AECB are bacterial in aetiology and patients are generally treated
empirically with orally administered antibacterial agents. Guidelines for the management of AECB have been developed by a number of
national health authorities and international organisations, with the aim of promoting rational selection of antibacterial therapy to
minimise the risk of treatment failure and subsequent hospitalisation while containing the development and spread of antibacterial
resistance. This paper reviews a number of recently published or updated AECB treatment guidelines, focusing on patient stratification
strategies, antibacterial treatment recommendations, and newer antibacterial treatment options, including respiratory fluoroquinolones
and the ketolide telithromycin, which have recently been added to a number of national treatment guidelines.
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
Acute exacerbations of chronic bronchitis; Antibacterials; Ketolides; Telithromycin; Treatment guidelines
Elenco autori:
F. Blasi, S.Ewig, A.Torres, G Huchon
Link alla scheda completa: